本文關(guān)鍵詞： 復(fù)方枸櫞酸阿爾維林 腸易激綜合征 預(yù)算影響分析　出處：《中國(guó)衛(wèi)生經(jīng)濟(jì)》2015年11期 　論文類(lèi)型：期刊論文

【摘要】：目的:為了對(duì)復(fù)方枸櫞酸阿爾維林(ACS)治療腸易激綜合征(IBS)進(jìn)行預(yù)算影響分析(BIA),為其報(bào)銷(xiāo)政策的制定提供參考。方法:采用文獻(xiàn)研究的方法,選定P.Ducrotte等在2013年報(bào)道的《枸櫞酸阿爾維林/西甲硅油按需治療與常規(guī)治療在腸易激綜合征治療方面的比較:一項(xiàng)隨機(jī)實(shí)用性研究的結(jié)果》為原始文獻(xiàn),對(duì)其ACS按需治療組和常規(guī)治療組的成本進(jìn)行本土化處理,按照中國(guó)的患病率和就診率,在直接成本和總成本口徑分別進(jìn)行BIA。結(jié)果:以全部患者都用常規(guī)治療的預(yù)算為基數(shù),隨著ACS按需治療人數(shù)比例的上升,可以節(jié)約的預(yù)算也逐步上升,在直接成本和總成本口徑最高分別可達(dá)377.36億元(45.90%)和427.87億元(41.14%)。結(jié)論:與常規(guī)治療相比,ACS按需治療可以大幅度地節(jié)約預(yù)算,值得納入報(bào)銷(xiāo)范圍。
[Abstract]:Objective: to analyze the budget impact of compound Alverin citrate (ACS) in the treatment of irritable bowel syndrome (IBS), and to provide a reference for the formulation of reimbursement policy. In 2013, P. Ducrotte et al., A comparison of Alverin citrate / methylsiloxane oil versus conventional therapy in the treatment of irritable bowel syndrome: the results of a randomized and practical study, were selected as the original literature. The cost of ACS on demand treatment group and routine treatment group were treated locally. According to the prevalence rate and the visiting rate in China, the ACS was carried out at the direct cost and the total cost caliber respectively. Results: based on the budget of routine treatment for all patients, As the proportion of people on demand for ACS increases, so does the budget savings. The highest direct cost and total cost can reach thirty-seven billion seven hundred and thirty-six million yuan or 45.90 yuan respectively) and forty-two billion seven hundred and eighty-seven million yuan or 41.14 yuan respectively. Conclusion: compared with conventional treatment, the on-demand treatment can save the budget greatly and is worthy of being included in the reimbursement scope.
【作者單位】： 上海應(yīng)用技術(shù)學(xué)院;上海市醫(yī)學(xué)科學(xué)技術(shù)情報(bào)研究所上海市衛(wèi)生發(fā)展研究中心;復(fù)旦大學(xué)公共衛(wèi)生學(xué)院;中國(guó)醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)院;博福益普生制藥有限公司;
【分類(lèi)號(hào)】：R574.4

【參考文獻(xiàn)】

相關(guān)期刊論文 前2條

1 潘國(guó)宗,魯素彩,柯美云,韓少梅,郭慧平,方秀才;北京地區(qū)腸易激綜合征的流行病學(xué)研究:一個(gè)整群、分層、隨機(jī)的調(diào)查[J];中華流行病學(xué)雜志;2000年01期

2 熊理守,陳e，

本文編號(hào)：1513861